|
US - Bristol-Myers Squibb Co acquired all the outstanding stock of Adnexus Therapeutics Inc, a manufacturer and developer of protein-based pharmaceutical products, for $### mil. The consideration was to consist of $### mil in cash and up to $##…
|
| Credit & Investment Research |
|
|